Climb Bio, Inc. (CLYM): Shareholders' Equity
$160.47M
As of 2025-12-31
$239.55M
As of 2026-06-30
+7.6%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $160.47M | -24.3% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $211.88M | +96.9% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $107.60M | -16.4% | 2025-03-25, Balance as of period end |
| 2022-12-31 | $128.72M | -23.0% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $167.20M | n/m | 2023-03-06, Balance as of period end |
| 2020-12-31 | -$24.98M | n/a | 2022-03-07, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | 2025-12-31 | $160.47M | -24.3% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 2025-12-31 | $147.50M | +3.6% |
| Eledon Pharmaceuticals, Inc. (ELDN) | 2025-12-31 | $81.08M | +29.8% |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $106.03M | +67.5% |
| Apimeds Pharmaceuticals US, Inc. (APUS) | 2025-12-31 | $153.35M | n/m |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | -$122.76M | n/m |
| Cypherpunk Technologies Inc. (CYPH) | 2025-12-31 | $153.51M | +338.0% |
| Transcode Therapeutics, Inc. (RNAZ) | 2025-12-31 | $10.34M | n/m |
| PepGen Inc. (PEPG) | 2025-12-31 | $147.44M | +24.3% |
Compare CLYM, CRBP, ELDN, GYRE side by side · Screen every company in Pharmaceutical Preparations ↗